Share this video  

ESMO 2022 | Small randomized trials to investigate optimal chemotherapy and immunotherapy combinations

Jon Amund Kyte, MD, PhD, University of Oslo, Oslo, Norway discusses investigating optimal chemotherapy and immunotherapies combinations with small randomized trials to expose large treatment benefits, as opposed to moderate benefits. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.